San Diego-based Althea Technologies, a contract development and manufacturing firm for the biopharmaceuticals industry, said today that it has acquired the assets and IP portfolio of Altus Pharmaceuticals. Financial terms of the deal were not disclosed. Altus Pharmaceuticals is a developer of controlled release injectable technologies, used for protein purification and catalysis.
Top NewsMonday, May 3, 2010
Althea Technologies Buys Altus Pharmaceuticals